May 12th 2021
This study evaluates the cost-effectiveness and budget impact to US payers of point-of-care nucleic acid amplification tests (NAAT) for group A streptococcus.
“Precision Health” for High-Need, High-Cost Patients
September 13th 2018Better care for high-need, high-cost patients will require targeted care delivery models based on integrated data networks that include clinical, genomic, and social information. Check out our website’s new table/figure pop-up feature! Click on the name of a table or figure in the text to see it in your browser.
Read More
How "Clinical Efficacy" Can Rein in Healthcare Costs
August 31st 2015The latest installment in the 20th anniversary commentary series in The American Journal of Managed Care explores the concept of "clinical efficacy." This healthcare delivery model asks stakeholders to make use of data and value-based contracts that reward early intervention in high-risk patients.
Read More
Misdiagnosis of Alzheimer's Disease Is Costly for Patients
August 3rd 2015The diagnosis and management of patients with dementing illnesses can be challenging, but the cost of misdiagnosing dementia as Alzheimer's disease can be as high as $14,000 a year, according to a study published in Alzheimer's & Dementia.
Read More
Budget to Offer Details of Personalized Medicine Initiative, While CMS Moves to Pay for Key Tests
January 26th 2015As the personalized medicine initiative takes shape, word comes that CMS will pay for key genetic tests in lung cancer. This policy shift is a sea change after a long period of frustration for test makers in seeking reimbursement.
Read More
Early Detection, Cutting Edge Treatments for Breast Cancer Patients
January 23rd 2015In 2 interviews with Physicians' Education Resource, LLC, award-winning journalist Joan Lunden and Patrick I. Borgen, MD, of Maimonides Medical Center in Brooklyn, NY, discuss breast cancer in advance of the 32nd Annual Miami Breast Cancer Conference.
Read More
Bigger Regulatory Challenges in Diagnostics Than in Therapeutics, Industry Expert Says
December 8th 2014Representatives from industry and the FDA share perspectives on the state of regulation for therapeutics and diagnostics at the 56th annual meeting of the American Society of Hematology, being held in San Francisco.
Read More
The toughest topics in cancer care will be on tap November 13-14, 2014, in Baltimore, Maryland, when AJMCLive presents Patient-Centered Oncology Care. If you've followed the discussion among pharmaceutical leaders, oncologists, and payers over access to care, you'll want to join stakeholders to discuss how to ensure patients get what they need while controlling costs.
Read More